JPH05276956A - ヒトＴ−細胞抗原レセプターＶβ１７鎖のコード部分を含む新規組換えＤＮＡ分子、それらの調製法、抗体及びそれらを含む薬剤 - Google Patents

ヒトＴ−細胞抗原レセプターＶβ１７鎖のコード部分を含む新規組換えＤＮＡ分子、それらの調製法、抗体及びそれらを含む薬剤

Info

Publication number
JPH05276956A
JPH05276956A JP4258117A JP25811792A JPH05276956A JP H05276956 A JPH05276956 A JP H05276956A JP 4258117 A JP4258117 A JP 4258117A JP 25811792 A JP25811792 A JP 25811792A JP H05276956 A JPH05276956 A JP H05276956A
Authority
JP
Japan
Prior art keywords
sequence
chain
human
antibody
recombinant dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4258117A
Other languages
English (en)
Japanese (ja)
Inventor
Francois Romagne
ロマニュ フランソワ
Agthoven Andre Van
バン アグトバン アンドル
Bernard Malissen
マリッセン ベルナール
Lydia Besnardeau
ベスナールド リディア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUNOTECH SA
Original Assignee
IMMUNOTECH SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMUNOTECH SA filed Critical IMMUNOTECH SA
Publication of JPH05276956A publication Critical patent/JPH05276956A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP4258117A 1991-09-26 1992-09-28 ヒトＴ−細胞抗原レセプターＶβ１７鎖のコード部分を含む新規組換えＤＮＡ分子、それらの調製法、抗体及びそれらを含む薬剤 Pending JPH05276956A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9112148 1991-09-26
FR9112148A FR2681875A1 (fr) 1991-09-26 1991-09-26 Nouvelles molecules de adn recombinants contenant la partie codante d'une chaine vb17 du recepteur pour l'antigene des cellules t, procede de preparation, anticorps et medicaments les renfermant.

Publications (1)

Publication Number Publication Date
JPH05276956A true JPH05276956A (ja) 1993-10-26

Family

ID=9417529

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4258117A Pending JPH05276956A (ja) 1991-09-26 1992-09-28 ヒトＴ−細胞抗原レセプターＶβ１７鎖のコード部分を含む新規組換えＤＮＡ分子、それらの調製法、抗体及びそれらを含む薬剤

Country Status (4)

Country Link
EP (1) EP0534878A1 (https=)
JP (1) JPH05276956A (https=)
CA (1) CA2079197A1 (https=)
FR (1) FR2681875A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023540796A (ja) * 2020-09-11 2023-09-26 ヤンセン バイオテツク，インコーポレーテツド ベータ鎖媒介性免疫を調節するための方法及び組成物

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021010857A (es) 2019-03-11 2021-12-15 Janssen Biotech Inc Anticuerpos biespecificos anti-v(beta17)/anti-cd123.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86278A (en) * 1988-05-04 2003-06-24 Yeda Res & Dev Endowing cells with antibody specificity using chimeric t cell receptor
US5216132A (en) * 1990-01-12 1993-06-01 Protein Design Labs, Inc. Soluble t-cell antigen receptor chimeric antigens

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023540796A (ja) * 2020-09-11 2023-09-26 ヤンセン バイオテツク，インコーポレーテツド ベータ鎖媒介性免疫を調節するための方法及び組成物
JP2025003970A (ja) * 2020-09-11 2025-01-14 ヤンセン バイオテツク，インコーポレーテツド ベータ鎖媒介性免疫を調節するための方法及び組成物

Also Published As

Publication number Publication date
EP0534878A1 (fr) 1993-03-31
FR2681875A1 (fr) 1993-04-02
FR2681875B1 (https=) 1995-01-06
CA2079197A1 (fr) 1993-03-27

Similar Documents

Publication Publication Date Title
RU2139934C1 (ru) Гуманизированные антитела и их использование
US8105830B2 (en) Polyspecific binding molecules and uses thereof
KR100227303B1 (ko) 인체 t 임파구 수용체의 베타 사슬의 가변성 영역을 코딩하는 뉴클레오티드 서열, 대응하는 펩티드 세그먼트 및 진단 및 치료 용도
US5506126A (en) Rapid immunoselection cloning method
EP0380068A1 (en) An expression system for production of chimeric monoclonal antibodies
US20040077842A1 (en) Method of producing biospecific molecules by protein trans-splicing
JP2000502562A (ja) 細胞活性化プロセスおよびそのための試薬
Choi et al. A method for production of antibodies to human T-cell receptor beta-chain variable regions.
Rogers et al. Identification and characterization of macaque CD89 (immunoglobulin A Fc receptor)
CA2998548A1 (en) Sequencing-directed selection of tumor theranostics
WO2023217062A1 (zh) 一种嵌合抗原受体及其应用
US5480895A (en) Method of producing antibodies to a restricted population of T lymphocytes, antibodies produced therefrom and methods of use thereof
US20190359677A1 (en) Novel t cell receptors and immune therapy using the same for the treatment of cancer and infectious diseases
JPH0591881A (ja) Ｔ細胞抗原レセプター鎖をコードする新規組換えｄｎａ分子、調製方法、抗体およびそれらを含む医薬
JPH05276956A (ja) ヒトＴ−細胞抗原レセプターＶβ１７鎖のコード部分を含む新規組換えＤＮＡ分子、それらの調製法、抗体及びそれらを含む薬剤
US20030068628A1 (en) Nucleotide sequences coding for variable regions of beta chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
WO2023185256A1 (zh) 特异性结合cd7的抗体及其在制备嵌合抗原受体中的应用
Abbasi-Kenarsari et al. Cloning and expression of CD19, a human B-cell marker in NIH-3T3 cell line
CN117083384A (zh) 工程细胞的基因转移载体和方法
JPH05211875A (ja) Ｔ細胞抗原リセプターＶβ２鎖をコードする領域を含む新規組換ＤＮＡ
JPH10155489A (ja) 組換え抗体及びそれをコードする核酸
WO2026056681A1 (zh) 靶向人cd33的人源化抗体及其应用
CN118271452A (zh) 抗crtam/抗pd-l1抗体及其应用
CN119462928A (zh) 特异性靶向cldn6的抗体及其在制备car-t细胞中的应用